Advertisement

Topics

Companies Related to "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" [Most Relevant Company Matches] - Page: 5 RSS

07:08 EDT 20th March 2019 | BioPortfolio

Here are the most relevant search results for "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma" found in our extensive corporate database of over 50,000 company records.

Showing "Monoclonal Antibody Therapy Vaccine Therapy Treating Patients With" Companies 101–125 of 5,500+

Relevant

QED Bioscience Inc.

QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout our history, our goals have remained unchanged: provide the best antibody products and services on the market and support our clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED.QED Bioscience develops novel monoclonal and polyclonal antibody prod...


Arbios Systems, Inc.

Arbios Systems, Inc. is developing proprietary medical devices and cell-based therapies to enhance the survival of millions of patients each year who experience, or are at risk for, life-threatening episodes of liver failure. The Arbios product candidate portfolio includes the SEPET™ Liver Assist Device, a novel blood purification therapy that provides enhanced “liver dialysis,” and the H...

Ancillary Care Solutions

Ancillary Care Solutions (ACS) is the nationwide leader in helping healthcare organizations, hospitals and physician groups establish, manage and turn around outpatient physical and occupational therapy programs. In addition to providing performance-based financial, operational and compliance services, ACS offers real-time physical therapy and occupational...


IntraOp Medical Corporation

IntraOp Medical Corporation provides innovative technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp is committed to providing the tools doctors need to administer intra-operative radiation therapy safely and effectively – for all cancer patients. The company’s flagship product, Mobetron, is the first fully p...

Signet Laboratories Incorporated

Signet Laboratories, Inc is a medical biotechnology company focused in fields of cancer and infectious disease(Sepsis). Signet has developed proprietary antibody systems for the detection and management of breast and prostate cancer and Sepsis. Signet's patented technology will provide for determining risk in "normal patients who may be at increased risk for developing cancer at a time when proac...

MEDINET Co., Ltd. and MaxCyte, Inc.

MEDINET is a world leading company in cell therapy, supporting medical service providers in Japan. Through its service, MEDINET provides medical institutions with advanced technologies and knowhow in: cell processing and culturing, quality control, and facility management with respect to the immuno-cell therapy. MEDINET has extensive experience in autologo...

OncoResponse

OncoResponse discovers and develops highly targeted and immuno-oncology therapeutic antibodies against novel cancer targets. Our most advanced program, ONCR-201 is an anti-EMP2 fully-human monoclonal antibody being developed for female malignancies. The OncoResponse discovery engine is working to increase the success rate of cancer immunotherapies by ident...

Dimension Therapeutics

Dimension Therapeutics is a gene therapy company focused on developing novel therapies to treat rare diseases. Launched by Fidelity Biosciences in 2013, the Dimension team comprises biotech industry veterans and renowned thought leaders in gene therapy and rare diseases. The company is focused on building its adeno-associated virus (AAV) therapeutic discov...

Cell Therapy Catapult

The Cell Therapy Catapult is a centre of translational excellence for cell therapy and regenerative medicine. Its vision is for the UK to be a global leader in the development, delivery and commercialisation of cell therapy, making it a location for business start-up and growth. Based in London at Guy's Hospital, the centre takes products into early clinical ...

Arch Oncology, Inc.

Arch Oncology, Inc. is a privately-held, clinical-stage immuno-oncology company focused on the discovery and development of best-in-class antibody therapies for the treatment of patients with cancer. The Company’s next-generation anti-CD47 antibodies are highly differentiated, with the potential to improve upon the safety and efficacy profile relative...

Immunological Resource Center

Polyclonal antiserum (mouse, rat, rabbit)Monoclonal antibody services (mouse, rat, hamster)Cell line cloningCryostorageCulture fluid productionAscites fluid productionELISA assayImmunoisotypingContract antibody manufacturer of monoclonals, polyclon

Lpath

Lpath, Inc., headquartered in San Diego, California, is a theranostics company focused on bioactive signaling lipids as targets for treating and diagnosing important human diseases. Lpath's lead product candidate, Sphingomab™, is a monoclonal antibody (mAb) against a validated cancer target, sphingosine-1-phosphate (S1P), and has demonstrated compelling results against six different forms of sol...

Thrombolytic Science, LLC

Thrombolytic Science, LLC (TSI) is a privately-held vascular health and biotechnology company leading development of a next-generation, life-saving therapy to transform traditional medical approaches for treating blood clots caused by ischemic stroke and heart attacks – interventions that have not changed in decades. The company’s vision is to ...

Tactile Medical

Tactile Medical headquartered in Minneapolis, MN is a leader in lymphedema and venous ulcer therapies, serving tens of thousands of patients throughout the U.S. The home therapy device company manufactures and provides products for patients with chronic edema, including the Flexitouch® System, an advanced pneumatic compression device and Entré System...

OncoPep

OncoPep is developing targeted immunotherapeutics to prevent the progression of cancer, prolong survival and restore the quality of life of patients. OncoPep’s lead program is a multi-peptide therapeutic vaccine for use in treating smoldering multiple myeloma. www.oncopep.com

OncoPep, Inc.

OncoPep is developing targeted immunotherapeutics to prevent the progression of cancer, prolong survival and restore the quality of life of patients. OncoPep’s lead program is a multi-peptide therapeutic vaccine for use in treating smoldering multiple myeloma. www.oncopep.com

TCA Cellular Therapy, LLC

Under the scientific guidance of cellular biologist, Jose J. Minguell, Ph.D., TCA Cellular Therapy, LLC is a biotherapeutic adult stem cell research and development company. The company has been recognized by the FDA as one of the top 10 U.S. companies researching stem cell therapies. Founded in 2006, the privately-held company is located in Covington, Lou...

Precision Antibody

Precision Antibody develops monoclonal antibodies for pharma, bio, federal, and academic research labs. Also known for large & small scale antibody production and biacore services.

U.S. Physical Therapy, Inc.          

Founded in 1990, U.S. Physical Therapy, Inc. operates 418 clinics in 42 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, non-surgical treatment of osteoarthritis, treatment for neurologically-related injuries and rehabilitation of injured workers. In additi...

Therachon

Therachon is developing an innovative therapy for achondroplasia, the leading cause of dwarfism in humans. Therachon’s therapy aims to restore normal bone growth and proportions in children with the disease. For more information visit www.therachon.com.

Atomic International

While our customers and products span the globe we remain a privately held, family-run company totally committed to quality, safety, customer satisfaction and the advancement of accelerator room technology. Today's most advanced cancer therapy centers throughout the world are recognizing the need for state-of-the-art Shieldray® Technology. Leading this movement to modernization, Atomic Interna...

Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers around the globe. For more than 20 years, these customers have chosen Biogenesis for its quality, reliability, and innovation. Our ongoing commitment to quality products and services is demonstrated by ...

NEMOD Biotherapeutics GmbH & Co. KG

NEMOD Biotherapeutics GmbH & Co. KG is a biotechnology company specialized in drug discovery and development in the field of oncology. NEMOD combines its expertise in tumor immunology, antibody technology, cellular engineering, glycobiology and dendritic cell biology to develop innovative anticancer therapy approaches.NEMOD’s business activities focus on the development of own therapeutics,...

Alliance Oncology

Alliance Oncology partners with hospitals and radiation oncologists to set a new standard of care for cancer patients. This is achieved through the establishment of state-of-the-art cancer centers or the enhancement of existing facilities with advanced technologies, including Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGR...

Novo Integrated Sciences

Through Novo Healthnet Limited, a wholly owned subsidiary of Novo Integrated Sciences, we deliver multi-disciplinary primary healthcare to over 400,000 patients annually through our 16 corporate-owned clinics and a contracted network of 88 affiliate clinics and 234 eldercare centric homes located across Canada. Our team of practitioners and staff are train...


More From BioPortfolio on "Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks